To Joshua Bauml, vice president, lung cancer area stronghold leader at J&J, the company’s experience in multiple myeloma is a blueprint for its strategy in lung cancer. “Look at what we’ve ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.

The Turquoise Takeover that spanned New Jersey from May 5-11 shined a spotlight on lung cancer awareness. Known as Lung Cancer Action Week, the event was designed to help raise awareness about ...

ST. PAUL, Minn., May 19 (UPI) --With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting the promise of an artificial intelligence ...

Despite years of warnings and a mountain of scientific evidence linking smoking to lung cancer, there remains one confounding question: Why do some smokers never get lung cancer? It’s a puzzle ...

The cancer has metastasized to the bone, according to a statement from Mr. Biden’s personal office. By Tyler Pager and Gina Kolata Reporting from Washington Former President Joseph R.

Heather Khalifa for the NY Post Mucinous adenocarcinoma is a rare type of cancer that can develop in any organ, especially the breast, colon, rectum and lung. DNA mutations cause abnormal cell ...

Patients with gastroesophageal reflux disease were found to be 51% more likely to develop lung cancer. Gastroesophageal reflux disease (GERD) is associated with a significant increase in the risk ...

May 14 (Reuters) - The U.S. Food and Drug Administration has approved AbbVie's (ABBV.N), opens new tab drug to treat adults with a type of lung cancer who have received previous treatment ...

May 13 (Reuters) - Britain's GSK (GSK.L), opens new tab and drug developer iTeos Therapeutics (ITOS.O), opens new tab said on Tuesday they have stopped developing an experimental lung cancer drug ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy without increasing the risk of severe lung inflammation (pneumonitis).

Lung cancer is one of the most challenging diseases, making early diagnosis crucial for effective treatment. Fortunately, advancements in artificial intelligence (AI) are transforming lung cancer ...